Skip to main content
. 2021 Oct 5;9(9):1066–1073. doi: 10.1002/ueg2.12151

FIGURE 2.

FIGURE 2

Cumulative incidence of developing metastases, with death (not related to esophageal adenocarcinoma or metastases) as competing risk. CI, confidence interval; EAC, esophageal adenocarcinoma